First-in-human study of dosimetry, safety and efficacy for [177Lu]Lu-P15-073: a novel bisphosphonate-based radioligand therapy (RLT) agent for bone metastases.
Saved in:
| Title: | First-in-human study of dosimetry, safety and efficacy for [177Lu]Lu-P15-073: a novel bisphosphonate-based radioligand therapy (RLT) agent for bone metastases. |
|---|---|
| Authors: | Zhao, Ruiyue1 (AUTHOR), Lv, Jie1 (AUTHOR), Li, Mingzhao2 (AUTHOR), Xu, Siran1 (AUTHOR), Liang, Wenhua3 (AUTHOR), Lin, Xinqing4 (AUTHOR), Gu, Di2 (AUTHOR), Zeng, Guohua2 (AUTHOR), Jin, Wenbin5 (AUTHOR), Yan, Qingsong1 (AUTHOR), Zhong, Huizhen1 (AUTHOR), Alexoff, David6 (AUTHOR), Ploessl, Karl6 (AUTHOR), Zhu, Lin1,5 (AUTHOR) zhulin@bnu.edu.cn, Kung, Hank F.6,7 (AUTHOR) kunghf@gmail.com, Wang, Xinlu1 (AUTHOR) 71lu@163.com |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. Feb2025, Vol. 52 Issue 3, p925-935. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16197070 |
|---|---|
| DOI: | 10.1007/s00259-024-06942-0 |
